A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern-Reference-Cited by-同舟云学术

A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern

Published:2022-03 Issue:3 Volume:3 Page:100280
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Kerrigan Kathleen,Jo Yeonjung,Chipman Jonathan,Haaland Benjamin,Puri Sonam,Akerley Wallace,Patel Shiven

Funder

Sanofi

National Cancer Institute

Boehringer Ingelheim

AstraZeneca

Takeda Pharmaceutical Company

Janssen Pharmaceuticals

National Institutes of Health

Merck

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. International Association for the Study of Lung Cancer Mesothelioma Task Force. Epidemiology of Enviornmental exposure and malignant mesothelioma;Liu;J Thorac Oncol,2017

2. The epidemiology of mesothelioma in historical context;McDonald;Eur Respir J,1996

3. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis;Lin;Lancet,2007

4. Asbestos exposure and neoplasia;Selikoff;JAMA,1964

5. Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma;Panou;J Clin Oncol,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial;Lung Cancer;2024-08

2. Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma;Journal of Thoracic Oncology;2024-04

3. Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer;Molecular Oncology;2024-03-08

4. ATG5 as biomarker for early detection of malignant mesothelioma;BMC Research Notes;2023-04-24

5. Intratumor microbiota as a novel potential prognostic indicator in mesothelioma;Frontiers in Immunology;2023-03-14